Novel Treatment Advances
and Approaches in the Management of Chronic Cough With Unexplained
Cause: Emerging Therapies for Improved
Clinical and Economic Outcomes
A continuing medical
education activity sponsored by NAMCP and AAMCN
Novel Treatment Advances and Approaches in the Management of Chronic
Cough With Unexplained Cause: Emerging Therapies for Improved
Clinical and Economic Outcomes is a two-part webinar series focusing
on the latest developments on chronic cough
These are archives of live webinars held between August 20 and
August 25, 2020.
If you participated in any of the live webinars, you are not
claim credit from the archive of that webinar.
By clicking on each of the titles, you will be able to participate
in each part.
It is not required that you participate in all three or in order.
These activities are valid from September 1, 2020 to September 1,
series is supported by an educational grant from Merck Sharp & Dohme
This activity is intended for healthcare professionals practicing in managed
Instructions for CME/NCPD: Complete the pre-test,
listen to the audio and view the slides, complete the post test, complete the
evaluation form and hit submit. You will be asked to enter your name and email
address on the pre-test, evaluation and post-test. If you close your internet
browser without completing the post test, you will have ONE more opportunity to
complete. A score of 70% must be achieved on the post test to receive continuing
education credits. If you do not pass the post test after two attempts, you will
not be eligible to try again. Once you complete the evaluation form and score
70% or higher on your post test, you will automatically be given your
Chronic cough, which is observed in approximately 12% of the US population, is
defined as a cough that lasts for more than 8 weeks. Patients with chronic cough
are often distressed by the condition, which can lead to depression, anxiety, a
decline in quality of life, and changes to their social activities. The
diagnosis and management of chronic cough can be challenging, with only
approximately 50% of patients receiving a diagnosis. Recent advances have been
made in the understanding and management of refractory chronic cough, with
several novel therapies being evaluated in ongoing clinical studies. This
educational activity will review the burden of chronic cough, discuss the
current recommendations for the management of patients with chronic cough, and
evaluate the latest clinical data regarding emerging pharmacotherapies for the
treatment of patients with refractory chronic cough.